Security · CUSIP 09061GAE1
BIOMARIN PHARMACEUTICAL INC
NOTE 0.750%10/1 · institutional ownership from 13F filings
13F holders
10
Shares held
872.9K
Value held
$966.1K
New / sold out
4 / 0
Added / reduced
0 / 0
net +67.0K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2017
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 660,000 | $732.0K | 0.00% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 85,000 | $94.0K | 0.00% |
| LOOMIS SAYLES & CO L P | 42,878 | $47.1K | 0.00% |
| Sun Life Financial INC | 31,000 | $34.0K | 0.00% |
| Commonwealth Equity Services, Inc | 21,000 | $23.0K | 0.00% |
| BLAIR WILLIAM & CO/IL | 13,000 | $14.0K | 0.00% |
| Veritable, L.P. | 10,000 | $11.0K | 0.00% |
| Cribstone Capital Management, LLC | 5,000 | $6.0K | 0.00% |
| Mascoma Wealth Management LLC | 3,000 | $3.0K | 0.00% |
| North Star Investment Management Corp. | 2,000 | $2.0K | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Sun Life Financial INC | New | +31,000 | – |
| Commonwealth Equity Services, Inc | New | +21,000 | – |
| Veritable, L.P. | New | +10,000 | – |
| Cribstone Capital Management, LLC | New | +5,000 | – |
Biggest sellers
Nothing to show.